Clinical trial
Irinotecan Compared With Combination Chemotherapy in Treating Patients With…
NCT00005036 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005036 |
|---|---|
| Title | Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer |
| Official title | A Randomized Phase III Equivalence Trial of Irinotecan (CPT-11) Versus Oxaliplatin (OXAL)/5-Fluorouracil (5-FU)/Leucovorin (CF) in Patients With Advanced Colorectal Carcinoma Previously Treated With 5-FU |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | SWOG Cancer Research Network Eastern Cooperative Oncology Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer and 6 more |
| Intervention type | Drug, Procedure |
| Interventions | irinotecan hydrochloride, oxaliplatin, leucovorin calcium, fluorouracil, quality-of-life assessment |
| Enrollment | 560 |
| Start date | Nov 1, 1999 |
| Primary completion | Dec 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | May 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: